XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Financial Instruments
9 Months Ended
Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
 
The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans.
 
The Company had various interest rate swap agreements designated and qualifying as accounting hedges during the reported periods. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses, less any ineffectiveness, in the condensed consolidated statements of income within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income on the condensed consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of September 30, 2020 and December 31, 2019.  
(in thousands)Carrying amount of the hedged assetCumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is includedSeptember 30, 2020December 31, 2019September 30, 2020December 31, 2019
Loans$— $474,957 $— $21,440 
Securities available-for-sale (1)
134,949 151,538 6,595 2,802 
(1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At both September 30, 2020 and December 31, 2019, the amounts of the designated hedged items were $88.2 million.

The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at September 30, 2020 and December 31, 2019, identified by the underlying interest rate-sensitive instruments.

(dollars in thousands)

 
September 30, 2020
Notional ValueWeighted- Average Remaining Maturity (years)Weighted-Average Ratio
Instruments Associated WithFair ValueReceivePay
Securities available-for-sale$88,200 3.4$(6,610)3-month LIBOR2.54 %
Total at September 30, 2020$88,200 3.4$(6,610)3-month LIBOR2.54 %

(dollars in thousands)


December 31, 2019
Notional ValueWeighted- Average Remaining Maturity (years)Weighted-Average Ratio
Instruments Associated WithFair ValueReceivePay
Loans$427,446 5.5$(21,551)3-month LIBOR2.86 %
Securities available-for-sale88,200 4.1(2,806)3-month LIBOR2.54 %
Total at December 31, 2019$515,646 5.3$(24,357)3-month LIBOR2.80 %

In June 2020, the Company terminated all fair value hedging relationships associated with loans, which resulted in swap termination payments to counterparties totaling $46.1 million. The corresponding loan fair value hedging adjustment as of the date of termination is being amortized over the remaining lives of the designated loans. As of September 30, 2020, the remaining unamortized loan fair value hedging adjustment was $44.3 million and the remaining lives of the designated loans have a weighted-average term to maturity of 13.4 years.

The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at September 30, 2020 and December 31, 2019.

(dollars in thousands)

 
September 30, 2020
NotionalWeighted- Average Remaining MaturityWeighted-Average Ratio
Cash Flow HedgesValue(years)Fair ValueReceivePay
Interest rate swaps$110,000 6.3$(17,177)3-month LIBOR2.88 %
Interest rate swaps100,000 3.2(8,705)1-month LIBOR2.88 %

(dollars in thousands)


December 31, 2019
NotionalWeighted- Average Remaining MaturityWeighted-Average Ratio
Cash Flow HedgesValue(years)Fair ValueReceivePay
Interest rate swaps$110,000 7.1$(8,390)3-month LIBOR2.88 %
Interest rate swaps100,000 4.0(5,040)1-month LIBOR2.88 %
These derivative financial instruments were entered into for the purpose of managing the interest rate risk of certain assets and liabilities. The Company pledged $33.7 million and $42.3 million of cash collateral to counterparties as security for its obligations related to these interest rate swap transactions at September 30, 2020 and December 31, 2019, respectively. Collateral posted and received is dependent on the market valuation of the underlying hedges.

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at September 30, 2020 and December 31, 2019.
 September 30, 2020December 31, 2019
(in thousands)Notional
Amount
Fair
Value
Notional
Amount
Fair
Value
Asset Derivatives    
Derivatives not designated as hedging instruments    
IRLCs$114,546 $3,116 $56,256 $910 
Total contracts
$114,546 $3,116 $56,256 $910 
Liability Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with loans$— $— $427,446 $(21,551)
Interest rate swaps associated with securities available-for-sale88,200 (6,610)88,200 (2,806)
Interest rate swaps associated with liabilities210,000 (25,882)210,000 (13,429)
Derivatives not designated as hedging instruments
Forward contracts118,000 (485)115,000 (153)
Total contracts
$416,200 $(32,977)$840,646 $(37,939)

The fair value of interest rate swaps was estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date.

The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three and nine months ended September 30, 2020 and 2019.

 Amount of Gain (Loss )Recognized in Other Comprehensive Income (Loss) in The Three Months EndedAmount of Loss Recognized in Other Comprehensive Income (Loss) in The Nine Months Ended
(in thousands)September 30, 2020September 30, 2019September 30, 2020September 30, 2019
Interest rate swap agreements$1,514 $(3,225)$(12,453)$(12,689)

The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three and nine months ended September 30, 2020 and 2019.

 Amount of Gain / (Loss) Recognized in the Three Months EndedAmount of Gain / (Loss) Recognized in the Nine Months Ended
(in thousands)September 30, 2020September 30, 2019September 30, 2020September 30, 2019
Asset Derivatives    
Derivatives not designated as hedging instruments    
IRLCs$2,834 $275 $2,206 $1,095 
Liability Derivatives    
Derivatives not designated as hedging instruments   
Forward contracts$(468)$526 $(332)$337 
  
The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of income during the three and nine months ended September 30, 2020 and 2019.
(in thousands)

Line item in the condensed consolidated statements of income
Three Months EndedNine Months Ended
September 30, 2020September 30, 2019September 30, 2020September 30, 2019
Interest income
Loans$— $(521)$(2,445)$(785)
Securities - taxable(229)(42)(479)(59)
Securities - non-taxable(242)— (472)72 
Total interest income
(471)(563)(3,396)(772)
Interest expense    
Deposits685 161 1,585 355 
Other borrowed funds721 136 1,632 249 
Total interest expense
1,406 297 3,217 604 
Net interest income
$(1,877)$(860)$(6,613)$(1,376)